|
| Press Releases |
|
 |
|
| Friday, November 15, 2019 |
|
|
Global BioLife to Present 3F Antimicrobial Fragrance at 2020 ASM Biothreats |
| Global BioLife Inc, the U.S.subsidiary of SGX-listed Singapore eDevelopment Ltd (SeD), will present research on its 3F Antimicrobial Fragrance as a new method to prevent and treat Tuberculosis at the 2020 ASM Biothreats conference, taking place from 28 to 30 January 2020 in Arlington, Virginia. more info >> |
|
| Tuesday, October 29, 2019 |
|
|
Global BioLife to present Functional Fragrance Formula at the American Society for Microbiology's Biothreats Conference as a New Method to Prevent and Treat Tuberculosis |
| SGX-listed Singapore eDevelopment Limited ("SeD", SGX:40V) wishes to announce that its biomedical subsidiary incorporated in Nevada, Global BioLife Inc. ("Global BioLife") will be presenting its research on its Functional Fragrance Formula ("3F") against tuberculosis at the 2020 American Society for Microbiology ("ASM") Biothreats Conference. more info >> |
|
| Wednesday, July 24, 2019 |
|
|
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit |
| SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce the results of clinical trials conducted on Laetose(TM), developed by its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"). more info >> |
|
| Wednesday, June 12, 2019 |
|
|
Global BioLife's 3F Mosquito Repellent Formula performs well in Independent Testing |
| SGX-listed Singapore eDevelopment Ltd (SeD) wishes to announce that its U.S. biomedical subsidiary Global BioLife Inc. has independently tested its new 3F Mosquito Formula which performs well against mosquitoes for six (6) to eight (8) hours. more info >> |
|
| Monday, January 28, 2019 |
|
|
Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis |
| SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial Fragrance, which shows efficacy against tuberculosis. more info >> |
|
| Wednesday, November 7, 2018 |
|
|
Singapore eDevelopment's Global BioLife to present Parkinson's Research at Neuroscience 2018 |
| Singapore eDevelopment (SGX: 40V) ("SeD") subsidiary, Global BioLife Inc. is pleased to announce that research of their promising drug platform, Linebacker, will be presented at Neuroscience 2018, the Annual Meeting for the International Society for Neuroscience (SfN) in San Diego, California. more info >> |
|
| Monday, June 18, 2018 |
|
|
Singapore eDevelopment Limited Announces Corporate and Business Update |
| The Board of Directors of Singapore eDevelopment Limited wishes to provide shareholders an update on the Group's operations. more info >> |
|
| Thursday, May 31, 2018 |
|
|
Singapore eDevelopment's Global BioLife develops Low Glycemic Modified Sugar |
| Singapore Exchange-listed Singapore eDevelopment Limited ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife, Inc. ("Global BioLife"), has developed a low glycemic index, naturally modified sugar - Laetose - which has the potential to affect the world's sugar market. more info >> |
|
| Thursday, March 1, 2018 |
|
|
Singapore eDevelopment's Global BioLife confirms LB2 efficacy against Ebola |
| Singapore eDevelopment (SGX: 40V; SeD) is pleased to announce biomedical subsidiary Global BioLife, Inc. has completed the initial Zaire Ebola research portion for the study of new anti-viral drug LB2, part of its new universal therapeutic drug platform, Linebacker. more info >> |
|
| Wednesday, November 1, 2017 |
|
|
Singapore eDevelopment's Global BioLife confirms 100% Repellency of 3F Mosquito Fragrance |
| SGX-listed Singapore eDevelopment Ltd (SeD) announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has completed development and testing of mosquito deterring technologies including fragrances, paints, and fabric. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
富士通など、AIとデータの連携による新たな価値創出と社会課題解決を推進する「一般社団法人xIPFコンソーシアム」を設立
Apr 15, 2026 10:40: JST
|
|
|
富士通と中国電力ネットワーク、再生可能エネルギーの導入拡大と送電設備保全高度化に向けた知的財産ライセンス契約を締結
Apr 15, 2026 10:20: JST
|
|
|
Doubleview Gold Corp. Announces Filing of Preliminary Economic Assessment Technical Report for the Hat Project
Apr 15, 2026 00:29 HKT/SGT
|
|
|
Datavault AI 與 AgSensor Solutions 宣布建立諮詢合作夥伴關係，將高價值農業數據資產代幣化
Apr 14, 2026 21:00 HKT/SGT
|
|
|
Datavault AI 与 AgSensor Solutions 宣布建立咨询合作伙伴关系，旨在将高价值农业数据资产代币化
Apr 14, 2026 21:00 HKT/SGT
|
|
|
Datavault AI and AgSensor Solutions Announce Consulting Partnership to Tokenize High-Value Agricultural Data Assets
Apr 14, 2026 21:00 HKT/SGT
|
|
|
寶潔與 OMP 於 2026 年 Gartner 供應鏈研討會暨博覽會（Gartner Supply Chain Symposium/Xpo 2026）展示邁向自主化、以決策為中心的規劃之路
Apr 14, 2026 21:00 HKT/SGT
|
|
|
宝洁与OMP在2026年Gartner供应链研讨会暨博览会（Gartner Supply Chain Symposium/Xpo 2026）上展示通往自主、以决策为中心的规划之路
Apr 14, 2026 21:00 HKT/SGT
|
|
|
P&G and OMP Showcase the Path to Autonomous, Decision-Centric Planning at Gartner Supply Chain Symposium/Xpo 2026
Apr 14, 2026 21:00 HKT/SGT
|
|
|
Wellgistics Health 與 Kare PharmTech 成立合資企業，將服務範圍擴展至 20 萬名以上患者
Apr 14, 2026 19:05 HKT/SGT
|
|
|
Wellgistics Health 与 Kare PharmTech 成立合资企业，服务覆盖范围将扩展至 20 万余名患者
Apr 14, 2026 19:05 HKT/SGT
|
|
|
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
Apr 14, 2026 19:05 HKT/SGT
|
|
|
全球運動品牌 U.S. Polo Assn. 推出《Field X Fashion》第三期
Apr 14, 2026 19:00 HKT/SGT
|
|
|
全球运动品牌U.S. Polo Assn. 推出《Field X Fashion》第三期
Apr 14, 2026 19:00 HKT/SGT
|
|
|
Global Sports Brand U.S. Polo Assn. Unveils Field X Fashion, Issue 3
Apr 14, 2026 19:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
